N/A (SANOFICONR)
Healthcare | Drug Manufacturers - General
₹5199.0
-0.21% (₹11.0)
Market Overview
| Market Cap | 119736090624 |
| Volume | 1119 |
| 52W High | ₹5894.5 |
| 52W Low | ₹4211.55 |
Key Ratios
| P/E Ratio | 59.75175 |
| EPS | 87.01 |
| Beta | 0 |
| Dividend Yield | 1.06% |
Financial Performance
Revenue Growth
0.337%
Profit Margin
0.2762%
ROE
0%
ROA
0%
Stock Analysis Score: 40/100
Growth Score: 40/100
Key Strengths:
- Excellent profit margins above 15%
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Hold - The stock shows mixed signals, monitor for improvements
Detailed Analysis
Growth: 0.3% revenue growth indicates weak business expansion.
Profitability: 27.6% profit margin shows excellent operational efficiency.
Returns: ROE of 0.0% demonstrates moderate return on shareholder investment.
Valuation: PE ratio of 59.8x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹11973.6Cr
- Beta: 0.00 (Market Volatility)
- 52-Week Range: ₹4211.6 - ₹5894.5
Last Updated: 2025-09-06 05:38:36